Comparing the Safety and Efficacy of Homologous and Heterologous COVID-19 Prime-boost Vaccination in Bahrain
Latest Information Update: 06 Feb 2023
At a glance
- Drugs Coronavirus vaccine-Wuhan Institute of Biological Products (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 23 Jan 2023 Results published in the Vaccine
- 25 Oct 2021 Status changed from recruiting to completed.
- 13 Aug 2021 New trial record